Furthermore, it is proposed to review the current understanding of the OX40–OX40L axis from a comparative perspective, focusing on CTCL and benign inflammatory dermatoses, particularly atopic dermatitis and psoriasis. This evidence concerns the gene TNFSF4 and primary cutaneous T-cell non-Hodgkin lymphoma.